Jun Sheng’s research while affiliated with Yunnan Agricultural University and other places

Objective: This study aims to investigate the structural and functional characteristics of walnut protein hydrolysates (WPHs) with different molecular weights prepared using protease from Dregea sinensis Hemsl, as well as the anti-fatigue effects of low-molecular-weight walnut protein hydrolysates (LWPs) and their impact on the cecal microbiota and faecal metabolism of mice. Methods: The anti-fatigue activity of WPHs with different molecular weights was evaluated, and the LWPs were analyzed in a centralized manner. A 28-day gavage study was conducted to assess LWP’s anti-fatigue benefits in mice, supplemented by metabolomic analysis to explore its impact on metabolic pathways. Results: Our findings revealed that LWP significantly outperformed unhydrolyzed walnut protein (WP) in terms of water retention, lipid retention, emulsifying properties, and foaming capacity. Notably, differential protein expression associated with LWP highlighted pathways related to antioxidant activity. In vivo studies showed that LWP markedly enhanced glycogen storage in the muscles and liver of mice, while reducing serum levels of serum urea nitrogen, lactate dehydrogenase, blood lactic acid, and creatine kinase. Furthermore, the levels of Superoxide Dismutase and Glutathione were significantly elevated, alongside a reduction in Malondialdehyde, indicating that LWP’s anti-fatigue effect is closely linked to improved oxidative stress resistance. Additionally, LWP promoted beneficial increases in microbial populations such as Akkermansia, Alistipes, Eubacterium, and Muribaculum, which are associated with enhanced fatigue resistance. Metabolomic analysis indicated significant enrichment in glycerophospholipid metabolism and amino acid biosynthesis, identifying key metabolites including palmitoylethanolamide and 4-methyl-5-thiazoleethanol, both of which are integral to health maintenance. Conclusions: LWP demonstrates a robust anti-fatigue effect, supported by its accessibility, straightforward preparation, and eco-friendly characteristics. These attributes suggest that LWP has promising potential for inclusion in health products aimed at enhancing vitality and combating fatigue.

Ulcerative colitis (UC) is a global disease for which there is little of effective treatment options, thus creating an urgent need for the development of new drug candidates from natural and functional foods. Amomum tsaoko Crevost et Lemarie is a kind of medicinal and food herb that is rich in flavonoids. However, the pharmacological effects of Amomum tsaoko flavonoids (ATF) on UC have not yet been reported. The present study established a mouse model of UC using 3% dextran sulfate sodium (DSS), and modern molecular biology techniques such as IHC, RT-qPCR, Western blot, and 16S rRNA gene analysis were used to investigate the effect of ATF in UC mice. The results demonstrated that a high dose of ATF (100 mg/kg) led to a significant restoration of body weight, disease activity index score, and colon length, in addition to ameliorating colonic tissue damage in UC mice. ATF reduced the serum levels of lipopolysaccharides (LPS), inhibited the activation of the colonic TLR4/NF-κB/NLRP3 signaling pathway, and increased the mRNA expression of tight junction proteins such as ZO-1 , Occludin , and Claudin4 . Furthermore, ATF was found to reduce the relative abundance of the DSS-induced conditional pathogenic ( Escherichia-Shigella , Colidextribacter , and Oscillibacter ), increase the potential probiotic taxa ( Akkermansia , Bifidobacterium and unclassified_f__Atopobiaceae ). Interestingly, these genera were found to be significantly correlated with the UC core phenotypic indicators. These findings indicated that ATF may alleviate UC symptoms by modulating the gut microbiota-LPS/TLR4/NF-κB/NLRP3 axis. The present study has the potential to serve as a valuable reference point for understanding the role of natural flavonoids in the prevention of inflammatory diseases, and to expand the future applications of ATF in the fields of food and medicine.

Selenium nanoparticles (SeNPs) have drawn considerable attention to biomedicine, the food industry, and cosmetics due to their strong antioxidant potential and low toxicity. However, their poor stability limits broader applications. A promising strategy to overcome this limitation involves combining SeNPs with polysaccharides. In this study, selenium nanoparticles (MOLP-SeNPs) were synthesized using Moringa oleifera Lam. polysaccharide (MOLP) as a stabilizer and dispersant within a redox system comprising sodium selenite and ascorbic acid. The structural characteristics of the synthesized MOLP-SeNPs were analyzed using spectroscopy. Additionally, their thermal and storage stability was evaluated, and their antioxidant activity was explored through simulated digestion in vitro and a HepG2 cell oxidative stress model. The results demonstrated that well-dispersed, zero-valent MOLP-SeNPs showing a mean particle size of 166.58 nm were synthesized successfully through an MOLP-to-sodium selenite ratio of 2.8:3 at pH 7.3 and 35 °C. The MOLP-SeNPs exhibited excellent stability during preparation. In simulated in vitro digestion and H2O2-induced oxidative stress experiments on HepG2 cells, MOLP-SeNPs displayed strong free radical scavenging capacity while improving antioxidant activity. Cellular experiments deeply revealed that pretreatment with MOLP-SeNPs significantly improved cell viability and provided a pronounced protective effect against oxidative damage. In conclusion, MOLP-SeNPs represent a novel antioxidant with promising applications in food and biomedicine.

Theophylline and caffeine reduce hepatic fat accumulation in NAFLD mice by activating TNF pathways and inducing p38MAPK/IL-1β/IL-6 expression, whereas the structurally similar theobromine lacks such effects.

Background Triple-negative breast cancer is a clinically aggressive malignancy with poorer outcomes versus other subtypes of breast cancer. Numerous reports have discussed the use of epigallocatechin-3-gallate (EGCG) against various types of cancer. However, the effectiveness of EGCG is limited by its high oxidation and instability. The Notch pathway is critical in breast cancer development and prognosis, and its inhibition is a potential treatment strategy. Results In this study, we investigated the effects of prodelphinidin B-2,3,3’’-O-gallate (named PB2,3,3’’/OG or compound 2) via chemical oxidation of EGCG on cell viability and the Notch1 signaling pathway in breast cancer cells. We found that compound 2 showed significant cytotoxicity against triple-negative breast cancer cells, with the half maximal inhibitory concentration (IC50) values ranging 20–50 µM. In MDA-MB453 cells, compound 2 inhibited proliferation, clone formation, and the expression of proteins involved in the Notch1 signaling pathway. Furthermore, compound 2 induced cell cycle arrest and apoptosis. Consistent with the results of in-vitro experiments, treatment with compound 2 significantly reduced tumor growth. Mechanistically, compound 2 directly bound to Notch1 with high binding affinity (dissociation constant: KD=4.616 × 10− 6 M). Conclusion Our finding suggested that compound 2 may be a promising agent for the development of novel anti-cancer therapy options.

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. Constipation is a prodromal symptom of PD. It is important to investigate the pathogenesis of constipation symptoms in PD. Rotenone has been successfully used to establish PD animal models. However, the specific mechanism of rotenone-induced constipation symptoms is not well understood. In this work, we found that constipation symptoms appeared earlier than motor impairment in mice gavaged with a low dose of rotenone (30 mg/kg·BW). Rotenone not only caused loss of dopaminergic neurons and accumulation of α-synuclein, but also significantly reduced serum 5-HT levels and 5-HTR4 in the striatum and colon. The mRNA expression of aquaporins, gastrointestinal motility factors (c-Kit, Cx43, smMLCK and MLC-3) in mouse colon was also significantly regulated by rotenone. In addition, both colon and brain showed rotenone-induced inflammation and barrier dysfunction; the PI3K/AKT pathway in the substantia nigra and colon was also significantly inhibited by rotenone. Importantly, the structure, composition and function of the gut microbiota were also significantly altered by rotenone. Some specific taxa were closely associated with motor and constipation symptoms, inflammation, and gut and brain barrier status in PD mice. Akkermansia, Staphylococcus and Lachnospiraceae_UCG—006 may play a role in exacerbating constipation symptoms, whereas Acinetobacter, Lactobacillus, Bifidobacterium, Solibacillus and Eubacterium_xylanophilum_groups may be beneficial in stimulating gastrointestinal peristalsis, maintaining motor function and alleviating inflammation and barrier damage in mice. In conclusion, low-dose rotenone can cause parkinsonism with constipation symptoms in mice by disrupting the intestinal microecosystem and inhibiting the PI3K-AKT pathway and gastrointestinal motility.

Parkinson’s disease (PD) is the second most common neurodegenerative disease, but the existing therapeutic drugs for PD have limitations; thus, there is an urgent need to discover new methods of prevention and treatment. Amomum tsaoko Crevost et Lemarie (AT) is a classic traditional Chinese medicine and food. Its main pharmacological effect is the regulation of the gastrointestinal tract. To date, no studies on the use of AT or its extracts to treat PD have been reported. In this study, a rotenone-induced PD mouse model was utilized to evaluate the protective effect of Amomum tsaoko flavonoids (ATFs) and to elucidate the role of the gut microbiota in this effect. The results demonstrated that ATFs not only ameliorated the motor and constipation symptoms but also reduced the loss of nigrostriatal dopaminergic neurons. Furthermore, ATFs reduced the expression of inflammation-related genes (TNF-α, IL-1β, IL-6, COX-2, and MCP-1) and increased the expression of gut barrier-related genes (Muc-2, ZO-1, Occludin, Claudin3, and Claudin4) in the colon. Notably, ATFs were able to reverse rotenone-induced gut dysbiosis, including a significant decrease in the abundance of conditionally pathogenic bacteria (Desulfovibrio, Provotellaceae UCG-001, the Lachnospiraceae_NK4A136_group, norank_f_Erysipelotrichacea, and the Eubacterium nodatum group) and an increase in the abundance of probiotics (Bifidobacterium and Faecalibaculum). Interestingly, these genera were found to be significantly associated with PD motor symptoms and constipation indicators. This suggests that ATFs have the potential to alleviate PD symptoms through the modulation of gut microbes. These findings provide a solid foundation for further investigations into the anti-PD mechanism of ATFs and their potential in the prevention and treatment of PD.

This study optimized the extraction process of crude polysaccharides from Panax notoginseng leaves (PNLP) using the ultrasonic-assisted dual-enzyme method through a single-factor combined with response surface experiment. The crude polysaccharides were subsequently purified and isolated with DEAE-Cellulose 52, followed by structural analysis, evaluation of antioxidant activity, and examination of digestive enzyme inhibition. The hypoglycemic effects of the purified components were further clarified. The results indicated that the optimized crude polysaccharide had an extraction yield of 17.13 ± 0.29%. The purified fraction PNLP-3 (eluted with 0.3 M NaCl) was obtained through DEAE-Cellulose 52 chromatography, exhibiting a total sugar content of 81.2% and a molecular weight of 16.57 kDa. PNLP is primarily composed of arabinose, galactose, and galacturonic acid, with molar percentages of 20.24%, 33.54%, and 24.27%, respectively. PNLP-3 is mainly composed of arabinose and galactose, with molar percentages of 29.97% and 49.35%, respectively. In this study of hypoglycemic activity, the IC50 values of PNLP-3 for α-glucosidase and α-amylase inhibition were 1.045 mg/mL and 9.53 mg/mL, respectively. Molecular docking results confirmed that PNLP-3 exhibits better inhibitory activity against α-glucosidase. Furthermore, PNLP-3 alleviated hyperglycemia in insulin-resistant HepG2 cells by enhancing glucose consumption and glycogen synthesis. The antioxidant activity of PNLP-3 exhibited a positive correlation with its concentration, potentially contributing to its hypoglycemic effects by reducing oxidative stress. These findings underscore the therapeutic potential of Panax notoginseng leaf polysaccharides in managing type 2 diabetes and offer new perspectives on the use of natural polysaccharides for regulating blood glucose.